Skip to main content
BioNTech SE (ETR:22UA)
Germany flag Germany · Delayed Price · Currency is EUR
86.15
+0.10 (0.12%)
Last updated: Apr 29, 2026, 10:07 AM CET

BioNTech SE Revenue

In the year 2025, BioNTech SE had annual revenue of 2.87B EUR with 4.32% growth. BioNTech SE had revenue of 907.40M in the quarter ending December 31, 2025, a decrease of -23.75%.

Revenue
2.87B
Revenue Growth
+4.32%
P/S Ratio
7.68
Revenue / Employee
367.61K
Employees
7,807
Market Cap
22.04B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.87B118.80M4.32%
Dec 31, 20242.75B-1.07B-27.96%
Dec 31, 20233.82B-13.49B-77.94%
Dec 31, 202217.31B-1.67B-8.78%
Dec 31, 202118.98B18.49B3,834.63%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Merck KGaA 21.10B
Siemens Healthineers AG 23.30B
Bayer Aktiengesellschaft 45.58B
Fresenius SE & Co. KGaA 22.87B
Sartorius Aktiengesellschaft 3.55B
Fresenius Medical Care AG 19.63B
Fielmann Group AG 2.42B
Ottobock SE & Co. KGaA 1.68B
Revenue Rankings

BioNTech SE News

More News